CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS AS A POTENTIAL BIOINDICATOR OF THE ENDOGENOUS MYELIN REPAIR CAPACITY IN EXPERIMENTAL MULTIPLE SCLEROSIS

CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS AS A POTENTIAL BIOINDICATOR OF THE ENDOGENOUS MYELIN REPAIR CAPACITY IN EXPERIMENTAL MULTIPLE SCLEROSIS

Bibliographic Details
Main Authors:	Mari Paz Serrano-Regal, Inmaculada Alonso-García, Celia Camacho-Toledano, Isabel Machin-Diaz, María Cristina Ortega, Leticia Calahorra, Diego Clemente
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123005742

Similar Items

Regulatory Cells in Multiple Sclerosis: From Blood to Brain
by: Leticia Calahorra, et al.
Published: (2022-02-01)

EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS
by: Mari Paz Serrano-Regal, et al.
Published: (2023-10-01)

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
by: Celia Camacho-Toledano, et al.
Published: (2022-11-01)

MYELOID-DERIVED SUPPRESSOR CELL BURDEN IN THE CNS AND BLOOD IS ASSOCIATED WITH DISEASE SEVERITY OF MULTIPLE SCLEROSIS PATIENTS
by: María Cristina Ortega, et al.
Published: (2023-10-01)

The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis
by: Carolina Melero-Jerez, et al.
Published: (2020-07-01)

The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis
by: Carolina Melero-Jerez, et al.
Published: (2019-07-01)

The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability
by: Verónica Moliné-Velázquez, et al.
Published: (2014-07-01)

Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation
by: Jordi Ochando, et al.
Published: (2019-03-01)

Antibodies to myelin lipids in multiple sclerosis
by: M. V. Ivanova, et al.
Published: (2017-02-01)

Myeloid-derived suppressor cells in Chronic myeloid leukemia
by: Cesarina eGiallongo, et al.
Published: (2015-05-01)

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
by: Andrew M. K. Law, et al.
Published: (2020-02-01)

Myelin imaging in amyotrophic and primary lateral sclerosis.
by: Kolind, S, et al.
Published: (2013)

Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
by: Edward L. Hogan, et al.
Published: (2013-08-01)

Myeloid-Derived Suppressor Cells in Sepsis
by: Irene T. Schrijver, et al.
Published: (2019-02-01)

Exploring in vivo lesion myelination dynamics: Longitudinal Myelin Water Imaging in early Multiple Sclerosis
by: Hagen H. Kitzler, et al.
Published: (2022-01-01)

Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress
by: Celia María Curieses Andrés, et al.
Published: (2023-01-01)

Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis
by: Eneritz López-Muguruza, et al.
Published: (2023-08-01)

Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis.
by: Lars Börnsen, et al.
Published: (2015-01-01)

Myeloid-Derived Suppressor Cells in Solid Tumors
by: Tianmiao Ma, et al.
Published: (2022-01-01)

Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
by: Nikoleta Bizymi, et al.
Published: (2021-12-01)

Myeloid-derived suppressor cells and pulmonary hypertension
by: Hui Zhang, et al.
Published: (2023-06-01)

Myeloid-Derived Suppressor Cells in Colorectal Cancer
by: Izabela Sieminska, et al.
Published: (2020-08-01)

Myeloid-Derived Suppressor Cells in Lung Transplantation
by: Tobias Heigl, et al.
Published: (2019-04-01)

Myeloid-derived suppressor cells in bacterial infections
by: Michael eOst, et al.
Published: (2016-03-01)

The Yin and Yang of Myeloid Derived Suppressor Cells
by: Snehil Budhwar, et al.
Published: (2018-11-01)

CD115− monocytic myeloid-derived suppressor cells are precursors of OLFM4high polymorphonuclear myeloid-derived suppressor cells
by: Yunyun Zou, et al.
Published: (2023-03-01)

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
by: Suncica Kapor, et al.
Published: (2021-06-01)

Myelin water imaging reflects clinical variability in multiple sclerosis
by: Kolind, S, et al.
Published: (2012)

Myelin water imaging reflects clinical variability in multiple sclerosis.
by: Kolind, S, et al.
Published: (2012)

Serum and Saliva Myelin Basic Protein as Multiple Sclerosis Biomarker
by: Mohammad Hossein Mirzaii-Dizgah, et al.
Published: (2021-05-01)

Myelin positron emission tomography (PET) imaging in multiple sclerosis
by: Daniele de Paula Faria
Published: (2020-01-01)

Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging.
by: Tobias Djamsched Faizy, et al.
Published: (2016-01-01)

Role of myeloid-derived suppressor cells in chronic brucellosis
by: Shuiping Hou, et al.
Published: (2024-01-01)

The Roles of Myeloid-Derived Suppressor Cells in Liver Disease
by: Chunye Zhang, et al.
Published: (2024-01-01)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
by: Seiji Mabuchi, et al.
Published: (2021-02-01)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
by: Yufei Wang, et al.
Published: (2020-09-01)

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
by: Iosif Papafragkos, et al.
Published: (2021-08-01)

The role of myeloid-derived suppressor cells in liver cancer
by: Shiyue Zhou, et al.
Published: (2023-05-01)

The role of myeloid derived suppressor cells in musculoskeletal disorders
by: Yi Ren, et al.
Published: (2023-03-01)

The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
by: Tandeka Magcwebeba, et al.
Published: (2019-04-01)